Methods and Systems for Treating Cancer Using Extremely Low Frequency Electromagnetic Fields
OwnerBalam-Quitze Ramosinventor
Life of this patent
Estimating the term…
Abstract
A method of treating cancer exposes the patient to extremely low frequency electromagnetic fields (ELF-EMF) and/or extremely low frequency modulated electromagnetic fields, wherein the electromagnetic fields have frequencies ranging from 1 Hz to 300 Hz for a treatment period. The electromagnetic field frequency varies depending on the type of cancer being treated. Treatment is applied through having one or more electromagnetic coils applied to the patient or by placing the patient within an electromagnetic field generating system; and continuing the exposure for the treatment period sufficient to induce cellular changes in cancer cells of the patient, the cellular changes inhibiting the growth and proliferation of the cancer cells.
Claims14
A method of treating cancer in a patient, the method comprising the steps of, first, allowing the exposure of a patient to an electromagnetic field;
- and, second, continuing the exposure for the treatment period sufficient to induce cellular changes in cancer cells of said patient, the cellular changes inhibiting the growth and proliferation of the cancer cells.
A system for treating cancer comprising:
- a first step of placing one or more electromagnetic coils, or other means of generating an EM field, configured to generate extremely low frequency electromagnetic fields (ELF-EMF) or extremely low frequency modulated electromagnetic fields with frequencies ranging from 1 Hz to 300 Hz near a patient, and a second step of providing a control system configured to activate the system to expose a cancer patient to the electromagnetic fields for a treatment period sufficient to induce cellular changes in cancer cells of the patient. This claim extends to the use of mechanical or acoustic signals at frequencies between 1 Hz and 300 Hz.
A method for the adjunct treatment of cancer, such as an enhancer of chemotherapeutic agents or as an adjunct treatment to surgery or radiation therapy. These fields have demonstrated the ability to enhance the uptake of chemotherapeutic agents.
Dependencies are inferred from the claim text.